Good to see them really pushing the oncology platform now.
-Notice the cash burn with the Ph3 costs is now around 20 million per year...
-They're still quoting the 30% retail share @ 6 million per month, with no mention of the hospital segment... what's the net profit on that? somewhere between 10-15 million per year?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable